Empagliflozin Protects Cardiac Mitochondrial Fatty Acid Metabolism in a Mouse Model of Diet-Induced Lipid Overload
ConclusionEmpagliflozin treatment preserves mitochondrial fatty acid oxidation in the heart under conditions of chronic lipid overload.
Source: Cardiovascular Drugs and Therapy - Category: Cardiology Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Type 2 | Diets | Empagliflozin | Endocrinology | Heart | Heart Failure | High Fat | Jardiance | Liver | Nutrition | SGLT2 Inhibitors | Study | Urology & Nephrology